Cargando…

Proteinuria as a Biomarker for COVID-19 Severity

BACKGROUND: Renal involvement in syndrome coronavirus 2 (SARS-CoV-2) infection has been retrospectively described, especially acute kidney injury (AKI). However, quantitative proteinuria assessment and its implication in coronavirus disease 2019 (COVID-19) remain unknown. METHODS: In this prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouahmi, Hajar, Courjon, Johan, Morand, Lucas, François, Juliette, Bruckert, Vincent, Lombardi, Romain, Esnault, Vincent, Seitz-Polski, Barbara, Demonchy, Elisa, Dellamonica, Jean, Boyer-Suavet, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985082/ https://www.ncbi.nlm.nih.gov/pubmed/33767630 http://dx.doi.org/10.3389/fphys.2021.611772

Ejemplares similares

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
por: Cremoni, Marion, et al.
Publicado: (2021)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
por: Ruetsch, Caroline, et al.
Publicado: (2021)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
por: Lateb, Maël, et al.
Publicado: (2019)

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
por: Brglez, Vesna, et al.
Publicado: (2020)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
por: Cremoni, Marion, et al.
Publicado: (2020)

COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France
por: Courjon, Johan, et al.
Publicado: (2021)

Soins Intensifs (SI) en Infectiologie : Retex Covid et perspectives
por: Scussel, R., et al.
Publicado: (2023)

New insights into proteinuria/albuminuria
por: Comper, Wayne D., et al.
Publicado: (2022)

Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study
por: Courjon, Johan, et al.
Publicado: (2017)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria
por: Louvois, Marion, et al.
Publicado: (2022)

Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study
por: Merindol, Julie, et al.
Publicado: (2023)

Lesson from the COVID-19 pandemic lockdown: A major change of hospital-diagnosed bacteremia epidemiology
por: Cauhapé, Vincent, et al.
Publicado: (2023)

Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity
por: Doyen, Denis, et al.
Publicado: (2022)

Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study
por: Bailly, Laurent, et al.
Publicado: (2022)

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
por: Cremoni, Marion, et al.
Publicado: (2022)

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
por: Chen, Bohan, et al.
Publicado: (2022)

Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemia
por: Saccheri, Clément, et al.
Publicado: (2023)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
por: Occelli, Céline, et al.
Publicado: (2022)

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
por: Allouche, Jonathan, et al.
Publicado: (2022)

Terahertz spectra of proteinuria and non-proteinuria
por: Xue, Zhenrui, et al.
Publicado: (2023)

Editorial: Immune dysfunction in nephrotic syndrome - recent advances and new roads ahead
por: Seitz-Polski, Barbara, et al.
Publicado: (2022)

Clindamycin Efficacy for Cutibacterium acnes Shoulder Device-Related Infections
por: Courdurié, Audrey, et al.
Publicado: (2022)

Treatment of proteinuria in dogs with telmisartan: A retrospective study
por: Lecavalier, Julie, et al.
Publicado: (2021)

Proteinuria in Diabetes
por: Thomas, Stephen, et al.
Publicado: (2000)

Composite Biomarkers Derived from Micro-Electrode Array Measurements and Computer Simulations Improve the Classification of Drug-Induced Channel Block
por: Tixier, Eliott, et al.
Publicado: (2018)

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
por: Gérard, Alexandre, et al.
Publicado: (2021)

Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity
por: Courjon, Johan, et al.
Publicado: (2021)

Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients
por: Cremoni, Marion, et al.
Publicado: (2022)

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients
por: Vitiello, Libero, et al.
Publicado: (2018)

Bone-to-Brain: A Round Trip in the Adaptation to Mechanical Stimuli
por: Gerosa, Laura, et al.
Publicado: (2021)

Molecular Mechanisms of Proteinuria in Minimal Change Disease
por: Purohit, Shrey, et al.
Publicado: (2021)

Nesprins and Lamins in Health and Diseases of Cardiac and Skeletal Muscles
por: Janin, Alexandre, et al.
Publicado: (2018)

Origin of Heart Rate Variability and Turbulence: An Appraisal of Autonomic Modulation of Cardiovascular Function
por: Lombardi, Federico, et al.
Publicado: (2011)

Role of the podocyte in proteinuria
por: Menzel, Sylvia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_239d1s93m0e21oj7b3mosg2ha5